The global market for Integrated Drug Discovery Service is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Integrated Drug Discovery Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Integrated Drug Discovery Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Integrated Drug Discovery Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Integrated Drug Discovery Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Integrated Drug Discovery Service players cover Syngene, Eurofins, Charles River, Evotec and BioAscent, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This latest report provides a deep insight into the global Integrated Drug Discovery Service market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Integrated Drug Discovery Service market, with both quantitative and qualitative data, to help readers understand how the Integrated Drug Discovery Service market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
The study segments the Integrated Drug Discovery Service market and forecasts the market size by Type (Ligand Based Drug Discovery, Structure Based Drug Discovery and Others), by Application (Biotech and Pharmaceutical Companies, Academic Institution and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Ligand Based Drug Discovery
Structure Based Drug Discovery
Segmentation by application
Biotech and Pharmaceutical Companies
Segmentation by region
Middle East & Africa
Major companies covered
Dalton Pharma Services
Aragen Life Sciences
Chapter 1: Scope of Integrated Drug Discovery Service, Research Methodology, etc.
Chapter 2: Executive Summary, global Integrated Drug Discovery Service market size and CAGR, Integrated Drug Discovery Service market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Integrated Drug Discovery Service revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Integrated Drug Discovery Service revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Integrated Drug Discovery Service market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Syngene, Eurofins, Charles River, Evotec, BioAscent, Sygnature Discovery, Jubilant Biosys, Charnwood Molecular and Domainex, etc.
Chapter 14: Research Findings and Conclusion